Document is current
Any future updates will be listed below
-
Authors
Stewart, Adam
Song, Jiin
Pickard, Lisa
Muggiolu, Giovanna
Sauvaigo, Sylvie
Brandon, Alexis De Haven
Raynaud, Florence
Banerji, Udai https://orcid.org/0000-0003-1503-3123
- License Information
-
More Information
Article History
Received: 19 October 2023
Revised: 29 January 2024
Accepted: 31 January 2024
First Online: 3 April 2024
Funding
: The authors would like acknowledge grant funding from Cancer Research UK (CRUK 23819) and infrastructural funding to the convergence science centre. The authors would also acknowledge infrastructural funding for the Experimental Cancer Medicine Centre and the NIHR biomedical research centre. UB has received NIHR funding (RP 2016-07-028).
: SRA737 was discovered in collaboration with HEI (higher education institution). The Institute of Cancer Research. AS, JS, LP, ADHB, FR and UB are employees of The Institute of Cancer Research. UB has spoken at Sierra Oncology advisory board (non-remunerated) and his institution has received funding to run clinical trials of SRA737. GN and SS are employees of LXRepair.
: No human participants or samples. Xenograft experiments carried out under home office license held by the Institute of Cancer Research. The authors consent for the publication of the manuscript.
